Pharmacologic enhancement of glymphatic flow to treat chronic pain

Description of the granted funding

Pain and pain-related conditions cause the highest burden of disease and are the leading cause of disability globally. Discovery of the glymphatic system provides new perspectives into the pathogenesis of chronic pain and opportunities for its treatment and prevention. The glymphatic system is active under natural deep sleep enabling the cerebrospinal fluid to flow through the brain and to clear the central nervous system of accumulated waste. This multidisciplinary preclinical study will be performed in rodents using state-of the art methods, such as a novel single-photon emission tomography tracking of cerebrospinal fluid flow. We will assess the hypothesis that pain-induced poor sleep leads to impaired glymphatic flow, poor clearance of proinflammatory cytokines, neuroinflammation, and consolidation of the chronic pain state. Ultimately, we will study if preclinically identified glymphatic enhancers could be used in rescuing glymphatic flow to alleviate chronic pain.
Show more

Starting year

2022

End year

2026

Granted funding

Tuomas Lilius Orcid -palvelun logo
254 434 €

Funder

Research Council of Finland

Funding instrument

Clinical researcher

Decision maker

Scientific Council for Biosciences, Health and the Environment
30.05.2022

Other information

Funding decision number

350371

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

brain, neuroscience